1. Pan-PIM kinase inhibitors enhance Lenalidomide's anti-myeloma activity via cereblon-IKZF1/3 cascade. (January 2019) Authors: Zheng, Jing; Sha, Yonggang; Roof, Logan; Foreman, Oded; Lazarchick, John; Venkta, Jagadish Kummetha; Kozlowski, Cleopatra; Gasparetto, Cristina; Chao, Nelson; Ebens, Allen; Hu, Jianda; Kang, Yubin Journal: Cancer letters Issue: Volume 440-441(2019) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗